**INTRODUCTION:** Fat grafting is an important and versatile procedure, but it is limited by unpredictable volume retention. Many studies have tried to correlate characteristics of grafted fat to retention, but this has been largely limited to animal models. Butala et al. demonstrated in mice that high-density fat is associated with increased graft retention, higher progenitor concentration, and fewer collagen bands.^1^ Similarly, previous work by our group demonstrated that CD34+ adipose stem cells (ASCs) are predictive of fat graft retention in mice.^2^ In this study, we aimed to examine the relationship between fat retention, cell type, and molecular characteristics in humans. We hypothesized that CD34+ ASCs are correlated with increased submetatarsal fat graft retention and lower collagen content in humans.

**METHODS:** Fat was harvested by manual liposuction and processed by standard Coleman technique from 24 patients undergoing fat grafting to the forefoot as part of a randomized cross-over clinical trial. Ultrasound-assessed submetatarsal tissue thickness was obtained at baseline, 6mo, & 12mo visits. Processed lipoaspirate was returned to the lab for stromal vascular fraction (SVF) isolation, flow cytometry characterization, collagen assessment using western blot, and histological imaging.

**RESULTS:** Average age was 63.6+/-6.7, and average BMI was 26.1+/-4.6. No patients were diabetic. Flow cytometry demonstrated that the proportion of CD34+ ASCs in the fat graft and the viability of the SVF isolate were correlated with significantly improved retention of tissue thickness at 6mo (p=0.044, p=0.033 respectively) but not at 12mo. Fat grafts with lower collagen1 concentration in western blots were associated with significantly greater SVF viability and CD34+ ASC content (p=0.046, p=0.005 respectively).

**CONCLUSION:** Volume loss after fat grafting remains a perplexing problem. The inverse association between collagen vs ASC content and SVF viability merits further study, particularly given the fact that ASC content and SVF viability predicted retention of tissue thickness at 6mo in grafted feet.

Reference Citations:
====================

1\. Butala P, Hazen A, Szpalski C, Sultan SM, Coleman SR, Warren SM. Endogenous stem cell therapy enhances fat graft survival. *Plast Reconstr Surg*. 2012;130(2):293--306. doi:10.1097/PRS.0b013e3182589c45.

2\. Philips BJ, Grahovac TL, Valentin JE, et al. Prevalence of Endogenous CD34+ Adipose Stem Cells Predicts Human Fat Graft Retention in a Xenograft Model. *Plast Reconstr Surg*. 2013;132(4):845--858. doi:10.1097/PRS.0b013e31829fe5b1.
